Revaluation of clopidogrel: let the data speak for themselves-Reference-Cited by-同舟云学术

Revaluation of clopidogrel: let the data speak for themselves

Published:2010-06 Issue:3 Volume:30 Page:299-306
ISSN:1672-0733
Container-title:Journal of Huazhong University of Science and Technology [Medical Sciences]
language:en
Short-container-title:J. Huazhong Univ. Sci. Technol. [Med. Sci.]

Author:

Liu Li,Zeng Fandian,Zeng Xiaohua,Xue Qingmei,Nie Shaoping,Kang Cailian,Wu Jianhong,Kang Qingyun,Wang Xingao,Liu Xiaoqing,Li Tao,Chen Jun,Li Qing,Xu Rong,Yang Xiaoyan,Kang Hui,Jiang Fagang,Li Zongtao,Wang Xuwu,Zhang Li,Long Yu

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biomedical Engineering,Biomaterials,Biochemistry

Link

http://link.springer.com/content/pdf/10.1007/s11596-010-0346-3.pdf

Reference60 articles.

1. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 1996, 348(9038): 1329–1339

2. Clopidogrel approved on basis of CAPRIE study [editorial]. Am J Health Syst Pharm, 1998,55(3):207

3. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation, 1999,100(9): 1016–1030

4. Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet, 2001,358(9292):1533–1538

5. Manolis AS, Tzeis S, Andrikopoulos G, et al. Aspirin and clopidogrel: a sweeping combination in cardiology. Curr Med Chem Cardiovasc Hematol Agents, 2005,3(3): 203–219

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient roots;Medical Hypotheses;2016-09